Tesa M Severson Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

1/2019

Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all-trans retinoic acid in acute myeloid leukemia across subtypes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tesa M Severson Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 02/2010
9	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2014
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2020
2	Pathologic Complete Response 08/2017 - 01/2017
1	Acute Promyelocytic Leukemia 01/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Squamous Cell Carcinoma of Head and Neck 04/2018
1	Hypersensitivity (Allergy) 04/2018
1	Male Breast Neoplasms (Male Breast Cancer) 01/2017
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2011
1	Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects 12/2010

Drug/Important Bio-Agent (IBA)

7	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2017
5	DNA (Deoxyribonucleic Acid)IBA 04/2018 - 08/2015
4	Hormones (Hormone)IBA 01/2021 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 11/2021 - 01/2020
3	Histones (Histone)IBA 01/2021 - 02/2010
3	ChromatinIBA 01/2021 - 06/2016
3	Estrogen Receptor alphaIBA 01/2018 - 06/2016
3	Estrogen ReceptorsIBA 01/2018 - 01/2014
3	Tamoxifen FDA LinkGeneric 06/2016 - 01/2014
2	AndrogensIBA 01/2022 - 01/2021
2	NucleotidesIBA 01/2020 - 12/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2018 - 08/2017
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2014
2	SteroidsIBA 01/2018 - 01/2017
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 06/2016
1	Pharmaceutical PreparationsIBA 01/2022
1	enzalutamideIBA 01/2022
1	Factor V (Coagulation Factor V)IBA 11/2021
1	CCCTC-Binding FactorIBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	RON proteinIBA 01/2020
1	macrophage stimulating proteinIBA 01/2020
1	LigandsIBA 01/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020
1	GSK2879552IBA 01/2019
1	Lysine (L-Lysine)FDA Link 01/2019
1	Cytostatic AgentsIBA 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019
1	A 19IBA 04/2018
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/2018
1	B7-H1 AntigenIBA 01/2018
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2018
1	Poly (ADP-Ribose) Polymerase-1IBA 01/2017
1	Carboplatin (JM8)FDA LinkGeneric 01/2017
1	veliparibIBA 01/2017
1	OligonucleotidesIBA 08/2015
1	human ERBB2 proteinIBA 01/2014
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2014
1	Insulin-Like PeptidesIBA 01/2014
1	MTOR InhibitorsIBA 01/2014
1	TensinsIBA 01/2014
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2014
1	TOR Serine-Threonine KinasesIBA 01/2014
1	SterolsIBA 12/2010
1	Histone MethyltransferasesIBA 02/2010

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2014
1	Castration 11/2021